Intellectual property law

Bicycle Therapeutics Enters Exclusive License and Collaboration Agreement with Ionis to Develop Targeted Oligonucleotide Therapeutics

Retrieved on: 
Tuesday, July 13, 2021

Ionis had an option for an exclusive license under the terms of a December 2020 evaluation and option agreement.

Key Points: 
  • Ionis had an option for an exclusive license under the terms of a December 2020 evaluation and option agreement.
  • Bicycle receives a total of $45 million upfront, which includes a license fee, an option fee, and an $11 million equity investment.
  • Bicycle is also eligible to receive development, regulatory and commercial milestone payments and royalties for each program developed under the collaboration.
  • This agreement stems from a highly successful collaboration with Ionis that began earlier in the year, during which Bicycles were shown to selectively deliver oligonucleotide payloads into TfR1-expressing tissue, said Kevin Lee, Ph.D., Chief Executive Officer of Bicycle Therapeutics.

ON24 Wins Top-Rated Award From Customers on TrustRadius

Retrieved on: 
Tuesday, July 13, 2021
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210713005053/en/
    ON24 wins Top-Rated Award based on customer reviews and ratings, ranking high in customer satisfaction and likelihood to recommend.
  • (Graphic: Business Wire)
    Were dedicated to the success of our customers and are grateful for their support and recognition, said Sharat Sharan, CEO of ON24.
  • The ON24 Digital Experience Platform includes ON24 Webcast Elite , ON24 Engagement Hub , ON24 Target , ON24 Virtual Conference, ON24 Intelligence , and ON24 Connect .
  • ON24 and the ON24 logo are trademarks owned by ON24, Inc., and are registered in the United States Patent and Trademark Office and in other countries.

Government of Canada takes action to protect Canadian research and intellectual property

Retrieved on: 
Monday, July 12, 2021

While remaining committed to preserving a collaborative and open approach to science and discovery, the Government of Canada is taking action to protect Canadian research and intellectual property against foreign interference, espionage and theft.

Key Points: 
  • While remaining committed to preserving a collaborative and open approach to science and discovery, the Government of Canada is taking action to protect Canadian research and intellectual property against foreign interference, espionage and theft.
  • Canadian researchersincluding those in government, academia and the private sectorshould increase their vigilance to protect the security of their research and intellectual property.
  • Researchers, research organizations and government all have a role to play in ensuring that Canadian research, knowledge and intellectual property are protected while continuing to advance the discoveries necessary for Canada to remain a global research and innovation leader.
  • By requiring that risk assessments be submitted with research funding requests, these new mandatory guidelines will help protect Canadian research, knowledge and intellectual property.

Omnicell Appoints Edward Bousa to Board of Directors

Retrieved on: 
Monday, July 12, 2021

We are pleased to welcome Ed to the Omnicell Board of Directors, said Randall Lipps, Chairman, President, Chief Executive Officer, and Founder of Omnicell.

Key Points: 
  • We are pleased to welcome Ed to the Omnicell Board of Directors, said Randall Lipps, Chairman, President, Chief Executive Officer, and Founder of Omnicell.
  • The addition of Mr. Bousa to Omnicells Board is part of the Boards ongoing refreshment process, which has resulted in the addition of two highly qualified new directors since 2019.
  • I am delighted to be joining the Omnicell Board at such an exciting time for the Company, said Mr. Bousa.
  • Omnicell is a registered trademark and the Omnicell logo is a trademark of Omnicell, Inc. in the United States and other countries.

ON24 Wins Top-Rated Award From Customers on TrustRadius

Retrieved on: 
Monday, July 12, 2021
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210712005141/en/
    ON24 wins Top-Rated Award based on customer reviews and ratings, ranking high in customer satisfaction and likelihood to recommend.
  • (Graphic: Business Wire)
    Were dedicated to the success of our customers and are grateful for their support and recognition, said Sharat Sharan, CEO of ON24.
  • The ON24 Digital Experience Platform includes ON24 Webcast Elite , ON24 Engagement Hub , ON24 Target , ON24 Virtual Conference, ON24 Intelligence , and ON24 Connect .
  • ON24 and the ON24 logo are trademarks owned by ON24, Inc., and are registered in the United States Patent and Trademark Office and in other countries.

PolarityTE Receives Notice of Allowance for Chinese Patent

Retrieved on: 
Monday, July 12, 2021

PolarityTE, Inc. (Nasdaq: PTE) today announced that the China National Intellectual Property Administration (CNIPA) issued a Notification of Allowance for Chinese Patent Application No.

Key Points: 
  • PolarityTE, Inc. (Nasdaq: PTE) today announced that the China National Intellectual Property Administration (CNIPA) issued a Notification of Allowance for Chinese Patent Application No.
  • The Company continues to pursue additional patent applications in the United States and abroad related to its regenerative technologies, including SkinTE.
  • David Seaburg, Chief Executive Officer, commented, In less than two years, PolarityTE has grown its worldwide patent portfolio from zero allowed or granted patents to 12.
  • POLARITYTE, the POLARITYTE logo, SKINTE, WHERE SELF REGENERATES SELF and WELCOME TO THE SHIFT are registered trademarks of PolarityTE, Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210712005140/en/

DSS’s Impact BioMedical Announces Second US Patent Issued for its Proprietary Equivir Compound

Retrieved on: 
Monday, July 12, 2021

ROCHESTER, N.Y., July 12, 2021 (GLOBE NEWSWIRE) -- Impact BioMedical Inc., a wholly owned subsidiary of Document Security Systems Inc. (NYSE American: DSS), today announced it was issued a patent (Patent # 11,033,528) on June 15, 2021, from the U.S. Patent and Trademark Office for its proprietary compound Equivir.

Key Points: 
  • ROCHESTER, N.Y., July 12, 2021 (GLOBE NEWSWIRE) -- Impact BioMedical Inc., a wholly owned subsidiary of Document Security Systems Inc. (NYSE American: DSS), today announced it was issued a patent (Patent # 11,033,528) on June 15, 2021, from the U.S. Patent and Trademark Office for its proprietary compound Equivir.
  • This patent is the second issued to Impact BioMedical for Equivir; the first (Patent # 10,383,842) was issued August 20, 2019, with claims directed to a method of limiting the occurrence of, reducing the risk or severity of, or treating influenza infection.
  • This is the second patent for Equivir and expands Impact BioMedicals intellectual properties in this area, said Frank D. Heuszel, CEO of DSS.
  • Mr. Chan Heng Fai, the Chairman of Document Security Systems, who owns Impact BioMedical, said that todays announcement highlights Equivirs potential versatility.

Woolpert Earns Trademark for Inspansion, a Method of Adding Capacity Through Analytics

Retrieved on: 
Friday, July 9, 2021

DAYTON, Ohio, July 9, 2021 /PRNewswire-PRWeb/ -- Woolpert has been granted a trademark for Inspansion, a method of adding capacity through analytics in place of physical expansion, by the U.S. Patent and Trademark Office.

Key Points: 
  • DAYTON, Ohio, July 9, 2021 /PRNewswire-PRWeb/ -- Woolpert has been granted a trademark for Inspansion, a method of adding capacity through analytics in place of physical expansion, by the U.S. Patent and Trademark Office.
  • He researched and employed nontraditional planning and operational strategies, such as expediting check-in processes and integrating additional technologies, to accommodate peak-hour passenger capacity without physically expanding the airport.
  • This strategic approach focused on operational process improvement and technology in lieu of more expensive capital development solutions.
  • "In addition to providing traditional planning for Sea-Tac, I was fortunate to head a think tank for strategic innovation," Tomber said.

Black Hills IP Launches DocketSaver™

Retrieved on: 
Thursday, July 8, 2021

MINNEAPOLIS, July 8, 2021 /PRNewswire/ -- Black Hills IP (BHIP), the nation's leading provider of fully automated docketing services for intellectual property attorneys, announces the release of DocketSaver, an easy-to-use verification tool that ensures docket entries are made as expected and helps eliminate docketing errors.

Key Points: 
  • MINNEAPOLIS, July 8, 2021 /PRNewswire/ -- Black Hills IP (BHIP), the nation's leading provider of fully automated docketing services for intellectual property attorneys, announces the release of DocketSaver, an easy-to-use verification tool that ensures docket entries are made as expected and helps eliminate docketing errors.
  • For example, in 2004, a leading IP law firm was ordered to pay $30 million for legal malpractice after failing to file a foreign patent application.
  • Once connected to a law firm's private USPTO account, DocketSaver trains itself based on the firm's docketing practices.
  • Minneapolis-based Black Hills IP is the nation's leading provider of fully automated docketing services for intellectual property attorneys.

NICE Selected as the Financial Services Finalist in 2021 Microsoft Partner of the Year Award Program

Retrieved on: 
Thursday, July 8, 2021

NICE (Nasdaq: NICE) today announced it has been selected as the financial services finalist in the 2021 Microsoft Partner of the Year Award Program.

Key Points: 
  • NICE (Nasdaq: NICE) today announced it has been selected as the financial services finalist in the 2021 Microsoft Partner of the Year Award Program.
  • NICE was chosen from among a global field of 4,400 top Microsoft partners for its innovation and excellence in delivering digital transformation solutions for financial services firms based on Microsoft technology.
  • As one of the first companies to offer a certified capture solution for Microsoft Teams, hosted in Microsoft Azure, NICE addresses this challenge.
  • Trademark Note: NICE and the NICE logo are trademarks or registered trademarks of NICE Ltd. All other marks are trademarks of their respective owners.